CJC-1295 no DAC and Ipamorelin blend This is a two peptide injectable blend of a growth hormone releasing hormone analogue and a ghrelin receptor agonist, sold as lyophilised powder for reconstitution and used to raise pulsatile growth hormone release.
- Two peptides hitting two separate receptors on one gland
- Growth hormone released in natural pulses, not a flat drip
- Ipamorelin is selective; no cortisol or prolactin spike
- The cleanest pharmacological logic in the secretagogue space
- Lyophilised powder; long shelf life until reconstituted
- Elegant mechanism; the long term human data is still being written
Mechanism
CJC-1295 without DAC is a tetrasubstituted analogue of growth hormone releasing hormone fragment 1-29 and acts at the pituitary GHRH receptor; ipamorelin is a selective growth hormone secretagogue receptor that mimics ghrelin at the same gland. Used together they raise growth hormone amplitude through two separate receptors, which is the pharmacological rationale for pairing them.
Safetyrisks and cautions, not medical advice
both components act on the growth hormone axis, an axis whose approved drugs are prescription only everywhere and whose self titration without IGF-1 monitoring risks insulin resistance, fluid retention and unopposed growth signalling
Where to buy
Suppliers
Vendors carrying CJC-1295 no DAC and Ipamorelin blend, with live product details and codes. Links are affiliate links that support the wiki at no cost to you.
RUPharma🌐
CJC-1295 no DAC and Ipamorelin blend